240 related articles for article (PubMed ID: 35583603)
1. Reduced bone mineral density in adolescents with Duchenne Muscular Dystrophy (DMD) and scoliosis.
Tsaknakis K; Jäckle K; Lüders KA; Lorenz HM; Braunschweig L; Hell AK
Osteoporos Int; 2022 Sep; 33(9):2011-2018. PubMed ID: 35583603
[TBL] [Abstract][Full Text] [Related]
2. Risk factors associated with prevalent vertebral fractures in Duchenne muscular dystrophy.
Phung K; McAdam L; Ma J; McMillan HJ; Jackowski S; Scharke M; Matzinger MA; Shenouda N; Koujok K; Jaremko JL; Smit K; Walker S; Hartigan C; Khan N; Konji VN; MacLeay L; Page M; Sykes E; Robinson ME; Alos N; Cummings EA; Ho J; Sbrocchi AM; Stein R; Saleh D; Craven BC; Dang UJ; Siminoski K; Rauch F; Ward LM
Osteoporos Int; 2023 Jan; 34(1):147-160. PubMed ID: 36342539
[TBL] [Abstract][Full Text] [Related]
3. Effects of Traction on Interpretation of Lumbar Bone Mineral Density in Patients with Duchenne Muscular Dystrophy: A New Measurement Method and Diagnostic Criteria Based on Comparison of Dual-Energy X-Ray Absorptiometry and Quantitative Computed Tomography.
Lee JS; Kim K; Jeon YK; Kim J; Jung DH; Kim SH; Shin MJ; Shin YB
J Clin Densitom; 2020; 23(1):53-62. PubMed ID: 30143440
[TBL] [Abstract][Full Text] [Related]
4. Bone Mineral Density Assessment by Quantitative Computed Tomography in Glucocorticoid-Treated Boys With Duchenne Muscular Dystrophy: A Linear Mixed-Effects Modeling Approach.
Liu C; Yang DD; Zhang L; Lei XG; Jia FL; Liao Y; Chen XJ; Ning G; Luo W; Qu HB
Front Endocrinol (Lausanne); 2022; 13():860413. PubMed ID: 35399923
[TBL] [Abstract][Full Text] [Related]
5. Different bone health progression patterns and early-stage risk marker in glucocorticoid-treated ambulatory Duchenne muscular dystrophy.
Zhou L; Zhou H; Xu H; Sun X; Chen X; Fan P; Cai X; Wang Q
Osteoporos Int; 2024 Jun; 35(6):997-1005. PubMed ID: 38277031
[TBL] [Abstract][Full Text] [Related]
6. Bone density and bone health alteration in boys with Duchenne Muscular Dystrophy: a prospective observational study.
Suthar R; Reddy BVC; Malviya M; Sirari T; Attri SV; Patial A; Tageja M; Didwal G; Khandelwal NK; Saini AG; Saini L; Sahu JK; Dayal D; Sankhyan N
J Pediatr Endocrinol Metab; 2021 May; 34(5):573-581. PubMed ID: 33838091
[TBL] [Abstract][Full Text] [Related]
7. Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates.
Catalano A; Vita GL; Bellone F; Sframeli M; Distefano MG; La Rosa M; Gaudio A; Vita G; Morabito N; Messina S
J Endocrinol Invest; 2022 Mar; 45(3):517-525. PubMed ID: 34524678
[TBL] [Abstract][Full Text] [Related]
8. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM
Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576
[TBL] [Abstract][Full Text] [Related]
9. The time to and determinants of first fractures in boys with Duchenne muscular dystrophy.
Ma J; McMillan HJ; Karagüzel G; Goodin C; Wasson J; Matzinger MA; DesClouds P; Cram D; Page M; Konji VN; Lentle B; Ward LM
Osteoporos Int; 2017 Feb; 28(2):597-608. PubMed ID: 27774565
[TBL] [Abstract][Full Text] [Related]
10. Discordantly high spinal bone mineral density values in patients with adult lumbar scoliosis.
Pappou IP; Girardi FP; Sandhu HS; Parvataneni HK; Cammisa FP; Schneider R; Frelinghuysen P; Lane JM
Spine (Phila Pa 1976); 2006 Jun; 31(14):1614-20. PubMed ID: 16778698
[TBL] [Abstract][Full Text] [Related]
11. Randomized Controlled Trial Evaluating the Use of Zoledronic Acid in Duchenne Muscular Dystrophy.
Zacharin M; Lim A; Gryllakis J; Siafarikas A; Jefferies C; Briody J; Heather N; Pitkin J; Emmanuel J; Lee KJ; Wang X; Simm PJ; Munns CF
J Clin Endocrinol Metab; 2021 Jul; 106(8):2328-2342. PubMed ID: 33954789
[TBL] [Abstract][Full Text] [Related]
12. Oral bisphosphonate treatment in patients with Duchenne muscular dystrophy on long term glucocorticoid therapy.
Tian C; Wong BL; Hornung L; Khoury JC; Rybalsky I; Shellenbarger KC; Rutter MM
Neuromuscul Disord; 2020 Jul; 30(7):599-610. PubMed ID: 32680651
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Neridronate in the Management of Bone Loss in Patients with Duchenne Muscular Dystrophy: Results from a Pilot Study.
Moretti A; Liguori S; Paoletta M; Gimigliano F; Iolascon G
Adv Ther; 2022 Jul; 39(7):3308-3315. PubMed ID: 35614293
[TBL] [Abstract][Full Text] [Related]
14. Scoliosis Treatment With Growth-Friendly Spinal Implants (GFSI) Relates to Low Bone Mineral Mass in Children With Spinal Muscular Atrophy.
Soini V; Hell AK; Metzger L; Jäckle K; Braunschweig L; Lüders KA; Lorenz HM; Tsaknakis K
J Pediatr Orthop; 2023 Aug; 43(7):431-439. PubMed ID: 37104756
[TBL] [Abstract][Full Text] [Related]
15. Thoracic bone mineral density measured by quantitative computed tomography in patients undergoing spine surgery.
Salzmann SN; Okano I; Jones C; Basile E; Iuso A; Zhu J; Reisener MJ; Chiapparelli E; Shue J; Carrino JA; Girardi FP; Cammisa FP; Sama AA; Hughes AP
Spine J; 2021 Nov; 21(11):1866-1872. PubMed ID: 34022462
[TBL] [Abstract][Full Text] [Related]
16. Progression of spinal deformity in wheelchair-dependent patients with Duchenne muscular dystrophy who are not treated with steroids: coronal plane (scoliosis) and sagittal plane (kyphosis, lordosis) deformity.
Shapiro F; Zurakowski D; Bui T; Darras BT
Bone Joint J; 2014 Jan; 96-B(1):100-5. PubMed ID: 24395319
[TBL] [Abstract][Full Text] [Related]
17. Vertebral Fractures in Duchenne Muscular Dystrophy Patients Managed With Deflazacort.
Singh A; Schaeffer EK; Reilly CW
J Pediatr Orthop; 2018 Jul; 38(6):320-324. PubMed ID: 27328118
[TBL] [Abstract][Full Text] [Related]
18. Survival of patients with Duchenne muscular dystrophy who underwent spinal deformity correction.
Arshad A; Tsirikos AI
Dev Med Child Neurol; 2024 Feb; 66(2):187-194. PubMed ID: 37482906
[TBL] [Abstract][Full Text] [Related]
19. Reduced Volumetric Bone Mineral Density of the Spine in Adolescent Rett Girls with Scoliosis.
Tsaknakis K; Kreuzer JH; Metzger FL; Jäckle K; Lüders KA; Braunschweig L; Lorenz HM; Hell AK
Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553345
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and bone metabolism in Duchenne muscular dystrophy.
Bianchi ML; Mazzanti A; Galbiati E; Saraifoger S; Dubini A; Cornelio F; Morandi L
Osteoporos Int; 2003 Sep; 14(9):761-7. PubMed ID: 12897980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
